Lantheus Holdings, Inc. OCI, before Reclassifications, Net of Tax, Attributable to Parent
Lantheus Holdings, Inc. (LNTH) reported OCI, before Reclassifications, Net of Tax, Attributable to Parent of -$143.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent · last filed 2025-05-07
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-03-31 was -$143.00K.
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2024-12-31 was -$449.00K.
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2024-09-30 was $44.00K.
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2024-06-30 was -$32.00K, a 107.51% decline year-over-year.
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for fiscal 2024 was -$578.00K, a 360.36% decline from fiscal 2023.
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for fiscal 2023 was $222.00K, a 95.84% decline from fiscal 2022.
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for fiscal 2022 was $5.33M, a 536.40% increase from fiscal 2021.
- Lantheus Holdings, Inc. oci, before reclassifications, net of tax, attributable to parent for fiscal 2021 was $838.00K.
| Period end | OCI, before Reclassifications, Net of Tax, Attributable to Parent 3 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 6 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 9 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$143.00K 10-Q · filed 2025-05-07 | -$592.00K derived: sum of 2 quarters · filed 2025-05-07 | -$548.00K derived: sum of 3 quarters · filed 2025-05-07 | -$580.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | -$449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$405.00K derived: sum of 2 quarters · filed 2025-02-26 | -$437.00K derived: sum of 3 quarters · filed 2025-02-26 | -$578.00K 10-K · filed 2025-02-26 |
| 2024-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $12.00K derived: sum of 2 quarters · filed 2024-11-06 | -$129.00K 10-Q · filed 2024-11-06 | -$131.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$173.00K 10-Q · filed 2024-07-31 | -$175.00K derived: sum of 3 quarters · filed 2025-05-07 | -$258.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-03-31 | -$141.00K 10-Q · filed 2025-05-07 | -$143.00K derived: sum of 2 quarters · filed 2025-05-07 | -$226.00K derived: sum of 3 quarters · filed 2025-05-07 | $200.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$85.00K derived: sum of 2 quarters · filed 2025-02-26 | $341.00K derived: sum of 3 quarters · filed 2025-02-26 | $222.00K 10-K · filed 2025-02-26 |
| 2023-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $343.00K derived: sum of 2 quarters · filed 2024-11-06 | $224.00K 10-Q · filed 2024-11-06 | $1.91M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $426.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $307.00K 10-Q · filed 2024-07-31 | $1.99M derived: sum of 3 quarters · filed 2024-07-31 | $3.01M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | -$119.00K 10-Q · filed 2024-05-02 | $1.56M derived: sum of 2 quarters · filed 2024-05-02 | $2.59M derived: sum of 3 quarters · filed 2024-05-02 | $2.99M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.71M derived: sum of 2 quarters · filed 2024-02-22 | $3.11M derived: sum of 3 quarters · filed 2024-02-22 | $5.33M 10-K · filed 2024-02-22 |
| 2022-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.42M derived: sum of 2 quarters · filed 2023-11-02 | $3.65M 10-Q · filed 2023-11-02 | $4.12M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.63M 10-Q · filed 2023-08-03 | $3.10M derived: sum of 3 quarters · filed 2023-08-03 | $2.77M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $2.23M 10-Q · filed 2023-05-04 | $2.70M derived: sum of 2 quarters · filed 2023-05-04 | $2.37M derived: sum of 3 quarters · filed 2023-05-04 | $2.43M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $143.00K derived: sum of 2 quarters · filed 2023-02-23 | $203.00K derived: sum of 3 quarters · filed 2023-02-23 | $838.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | -$328.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$268.00K derived: sum of 2 quarters · filed 2022-11-03 | $367.00K 10-Q · filed 2022-11-03 | $657.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $695.00K 10-Q · filed 2022-08-04 | $985.00K derived: sum of 3 quarters · filed 2022-08-04 | $914.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $635.00K 10-Q · filed 2022-04-29 | $925.00K derived: sum of 2 quarters · filed 2022-04-29 | $854.00K derived: sum of 3 quarters · filed 2022-04-29 | $566.00K derived: sum of 4 quarters · filed 2022-04-29 |
| 2020-12-31 | $290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $219.00K derived: sum of 2 quarters · filed 2022-02-24 | -$69.00K derived: sum of 3 quarters · filed 2022-02-24 | -$1.50M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$359.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.79M 10-Q · filed 2021-11-04 | -$1.76M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$288.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$1.72M 10-Q · filed 2021-07-28 | -$1.69M derived: sum of 3 quarters · filed 2021-07-28 | -$1.72M derived: sum of 4 quarters · filed 2021-07-28 |
| 2020-03-31 | -$1.43M 10-Q · filed 2021-05-04 | -$1.40M derived: sum of 2 quarters · filed 2021-05-04 | -$1.43M derived: sum of 3 quarters · filed 2021-05-04 | -$1.34M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.00K derived: sum of 2 quarters · filed 2021-02-25 | $92.00K derived: sum of 3 quarters · filed 2021-02-25 | $148.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $55.00K derived: sum of 2 quarters · filed 2020-11-05 | $111.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $144.00K 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $56.00K 10-Q · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |